Radioimmunotherapy as a targeted strategy of reduced-intensity conditioning for allogeneic transplantation in leukemia

• by Phuong T. Vo, Johnnie J. Orozco, Brenda M. Sandmaier

• June 23, 2026

Impact of haematopoietic stem cell transplantation for benign and malignant haematologic and non-haematologic disorders on fertility: a systematic review and meta-analysis

• by Angela Vidal, Cristina Bora, Andrea Jarisch, Janna Pape, Susanna Weidlinger, Tanya Karrer, Michael von Wolff

• February 26, 2025

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

• December 17, 2025

• 4 min

Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies

• by Francesca Salvagno, Bernadette Evangelisti, Marta Agù, Roberta Aprile, Stefano Canosa, Carlotta Paschero, Erica Silvestris, Giacomo Corrado, Gianluca Gennarelli, Alberto Revelli

• May 15, 2026